Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Abstract
Efficient Method for the Synthesis of Fingolimod and Impurities
Author(s): Maruthi Raju N, Venkateswara Rao B, Siddaiah VFingolimod (1b) is an immunomodulating, United States Food and Drug Administration (USFDA) approved Active Pharmaceutical Ingredients (API), which is one of the best drugs available for the treatment of Multiple Sclerosis (MS). Fingolimod was synthesized in seven steps using cheapest commercially inexpensive raw material octanophenone which meets high yield and purity. While developing the process of Fingolimod, some related impurities were observed. These impurities were recognized as Heptyl PNP (2a), Octyl PNP (2b), Nonyl PNP (2c), Nitro heptyl (3a), Nitro octyl (3b), Nitro nonyl (3c), Heptyl (1a) and Nonyl (1c) impurities. The present work explains the synthesis of fingolimod, its impurities and their characterization.
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 15261
Der Pharma Chemica received 15261 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
